• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-Q260J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 01/28/2023
Event Type  Injury  
Event Description
Olympus reviewed the following literature "underwater endoscopic mucosal resection with submucosal injection and marking' for superficial non-ampullary duodenal epithelial tumors to achieve r0 resection: a single-center case series." abstract objectives: to describe an endoscopic technique named ¿underwater endoscopic mucosal resection (uemr) with submucosal injection and marking (uemr-sim)¿ and to evaluate the therapeutic characteristics of superficial non-ampullary duodenal epithelial tumors (snadets) < 20mm vis-a-vis classical emr (cemr) and uemr techniques.Materials and methods: this retrospective study included 103 consecutive snadet patients (103 lesions) who underwent cemr, uemr, or uemr-sim.The uemr-sim procedure included (1) marking and submucosal injection, (2) filling of the duodenal lumen with 0.9% saline, (3) snaring of the lesion, and (4) electrosurgical removal.The procedural outcomes were compared between the uemr-sim and other-procedure groups.Results: the en bloc resection rate was significantly higher in the uemr-sim group (100%) than in the cemr group (76.8%) (p.0.015) but was not statistically different between the uemr-sim and uemr groups (88.0%) (p.0.236).The r0 resection rate was significantly higher in the uemr-sim group (90.9%) than in the uemr group (48.0%) (p.0.001) but was not statistically different between the uemr-sim and cemr groups (76.8%) (p.0.209).¿type of adverse events/number of patients¿ delayed bleeding (1) the delayed-bleeding case was an 8-mm flat lesion in the second portion of the duodenum in a 70-year-old man who had been taking warfarin due to atrial fibrillation.Cemr was performed with continued warfarin therapy, and the mucosal defect was completely closed.However, delayed bleeding occurred 3 and 6 days post-cemr, requiring endoscopic hemostasis twice and hospitalization for 18 days.Only one case showed a local recurrence after 32.4 months in the cemr group, whereas no local recurrences were observed in the uemr and uemr-sim groups.The local recurrence was successfully treated with salvage endoscopic mucosal dissection (esd).
 
Manufacturer Narrative
This report is related to the following linked patient identifiers: (b)(6).The device was not returned.Should additional relevant information become available, a supplemental report will be submitted.Doi.Org/10.1080/00365521.2023.2171315 provided for additional information.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18774960
MDR Text Key336207855
Report Number9610595-2024-03908
Device Sequence Number1
Product Code FDS
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-Q260J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/30/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
COLONOSCOPE (PCF-H290TI); HEMOSTATIC CLIP (HX-110QR)
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
Patient SexMale
-
-